On Friday, Mural Oncology plc (NASDAQ: MURA) was 8.40% up from the session before settling in for the closing price of $3.69. A 52-week range for MURA has been $2.87 – $5.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 6.94% over the past five years. When this article was written, the company’s average yearly earnings per share was at 39.05%. With a float of $15.55 million, this company’s outstanding shares have now reached $17.04 million.
Let’s look at the performance matrix of the company that is accounted for 117 employees. In terms of profitability, gross margin is 9.89%, operating margin of -6146.68%, and the pretax margin is -5798.36%.
Mural Oncology plc (MURA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mural Oncology plc stocks. The insider ownership of Mural Oncology plc is 8.82%, while institutional ownership is 61.76%. The most recent insider transaction that took place on Dec 23 ’24, was worth 8,355. In this transaction an insider of this company sold 2,555 shares at a rate of $3.27, taking the stock ownership to the 41,295 shares. Before that another transaction happened on Dec 23 ’24, when Company’s CLO proposed sale 2,555 for $3.25, making the entire transaction worth $8,304.
Mural Oncology plc (MURA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.05% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
You can see what Mural Oncology plc (MURA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.14, a number that is poised to hit -2.01 in the next quarter and is forecasted to reach -4.94 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
Mural Oncology plc (NASDAQ: MURA) saw its 5-day average volume 0.23 million, a negative change from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 67.83%. Additionally, its Average True Range was 0.26.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 81.29%, which indicates a significant decrease from 91.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.82% in the past 14 days, which was higher than the 51.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.58, while its 200-day Moving Average is $3.48. Nevertheless, the first resistance level for the watch stands at $4.16 in the near term. At $4.33, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.56. If the price goes on to break the first support level at $3.76, it is likely to go to the next support level at $3.53. Assuming the price breaks the second support level, the third support level stands at $3.36.
Mural Oncology plc (NASDAQ: MURA) Key Stats
There are 17,020K outstanding shares of the company, which has a market capitalization of 68.24 million. As of now, sales total 0 K while income totals -207,450 K. Its latest quarter income was 0 K while its last quarter net income were -31,760 K.
